Astegolimab (MSTT 1041A, RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research.
Purity:
>99.0%
CAS Number:
[2173054-79-8]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted